Radiolabeled somatostatin-derived peptides for imaging

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/655 (2006.01) A61K 51/08 (2006.01)

Patent

CA 2347670

This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic agents. Specifically, the invention relates to cyclic peptide derivatives and analogues of somatostatin, and embodiments of such peptides radiolabeled with a radioisotope, as well as methods and kits for making, radaolabeling and using such peptides for radiodiagnostic and radiotherapeutic purposes. The invention specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with technetium-99m and uses thereof as scintigraphic imaging agents. The invention also specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with cytotoxic radioisotopes such as rhenium-186 (186Re) and rhenium-188 (188Re) for use as radiotherapeutic agents. Methods and kits for making, radiolabeling anal using such peptides diagnostically and therapeutically in a mammalian body are also provided.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Radiolabeled somatostatin-derived peptides for imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radiolabeled somatostatin-derived peptides for imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled somatostatin-derived peptides for imaging will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1573309

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.